News Detail
New Delhi, 27 Feb 2025: Following its decision to make applications for clinical trial site addition and change of Principal Investigator available online, the Central Drugs Standard Control Organisation (CDSCO) has announced that similar applications for clinical trials of biolo......
View Details
Source : Pharmabiz
clinical trial site
Principal Investigator
CDSCO
regulatory submission procedure
Sugarm Portal
Global Clinical Trials
New Drugs
bioavailability
bioequivalence
rDNA
Clinical Trial Site Addition
PSUR
Post Approval Changes
PACs
National Single Window System
NSWS
Related News
- Centre to review safety, efficacy norms for 13 ‘very old’ drugs (27-02-2025)
- 26 cases filed against Patanjali in Kerala courts so far, related to DMR Act violations (27-02-2025)
- Current antivenom ineffective against a saw-scaled viper bite: Study (27-02-2025)
- Hyderabad: ED attaches JR Infinity’s Rs 7.98 crore assets over online sale of illegal drugs (27-02-2025)
- Need For Stringent Regulations, Quality Control In Nutraceuticals Market: Ayush Official (26-02-2025)
- DCA Raids: Fake supplements, bogus cures for diabetes, kidney stones seized in Musheerabad, Sangareddy (26-02-2025)
- Will the Centre compensate for adverse Covid vaccine effects? SC seeks govt reply on framing policy (26-02-2025)
- Indian drugmakers to stay competitive despite US tariff plans: Dr Reddy's (26-02-2025)
- Regulatory standards must be stronger for quality medicines: Health secy (26-02-2025)
- CDSCO asks State drug regulators to keep vigil against use of nimesulide in animals (26-02-2025)